TRIM-edicine

Leadership

TRIM-edicine has top-notch scientific leadership. To complement its strong scientific leadership, the company is currently seeking a qualified individual for the position of COO. Additionally, TRIM-edicine is searching for another individual with experience in regulatory affairs, either to join the company’s management team, or as a member of its board of directors or scientific advisory board. This will become increasingly important as TRIM-edicine prepares investigational new drug applications and begins clinical evaluations of its products.

Dr. Jianjie Ma, Ph.D., is the Founder and President of TRIM-edicine. He is currently a University Professor at Robert Wood Johnson Medical School (RWJMS), and Director of a joint Graduate Program in Physiology and Integrative Biology between RWJMS and Rutgers University. Dr. Ma obtained his bachelor’s degree in Physics from Wuhan University in China and Ph.D. in Physiology and Biophysics at Baylor College of Medicine. He serves on the editorial board of several major scientific journals and has authored or co-authored over 100 articles in peer-reviewed scientific journals. He is an Established Investigator from the American Heart Association, and frequently serves as a study section member for the National Institutes of Health. His research interests are in gene discovery and protein therapy in geriatric medicine, tissue repair, muscular dystrophy, cardiovascular disease, and cancer biology.

Dr. Noah Weisleder, Ph.D., is a co-founder of TRIM-edicine and serves as the Chief Scientific Officer. Dr. Weisleder received his bachelor’s degree with distinction from Worcester Polytechnic Institute, and his Ph.D. in Molecular and Cellular Biology from Baylor College of Medicine. Dr. Weisleder is a member of several scientific societies, including the American Association for the Advancement of Science (AAAS), the American Heart Association – Council on Basic Cardiovascular Sciences, the American Society of Cell Biologists, the Biophysical Society, the International Society for Heart Research, and the New York Academy of Sciences. He has authored or co-authored several publications based upon his doctoral and post-doctoral work in peer-reviewed scientific journals, including Nature, Nature Cell Biology, PNAS, Journal of Cell Biology and Journal of Cell Science.